Cantel Medical Corp. (CMN) Tops Q2 EPS by 2c; Revs Heavy

Cantel Medical Corp. (NYSE: CMN) reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $97.3 million versus the consensus estimate of $94.5 million.

For earnings history and earnings-related data on Cantel Medical Corp. (CMN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Cloudastructure reports 164% subscription revenue growth in Q2 2026